Products

PROTECT COGNITIVE HEALTH STARTING TODAY

FontUp® has demonstrated cognitive benefits in individuals at risk of developing Alzheimer's

Clear all

Clinically proven

FontUp® has demonstrated cognitive benefits in people at risk of developing Alzheimer's disease.

The PENSA study evaluated FontUp® within the framework of a multimodal lifestyle intervention that included: Mediterranean diet, physical exercise, and cognitive stimulation
Improved cognitive performance

After 12 months, the group that received FontUp® showed a 50% greater improvement in overall cognition compared to the placebo group. Furthermore, almost half of the participants treated with FontUp® (48%) improved their cognitive performance, compared to 27% in the placebo group.

Sustained effect over time

The benefits observed in cognitive function were maintained even three months after the intervention ended, indicating a persistent effect beyond the period of consumption.

It reduces the risk of developing dementia

In one year of intervention with FontUp® , the risk of developing dementia was reduced by 25%, as assessed by the LIBRA Index, a validated tool for estimating long-term dementia risk.

Science and first-person experience

"The focus must be on prevention. If we want to tackle the issue of neurodegenerative diseases, it's with prevention, prevention, and prevention" - TV3.

Dr. Rafael de la Torre, coordinator of the PENSA study and researcher at IMIM.

“FontUp is a very good product for memory preservation and stimulation.”

Anonymous

“I am a new person, my life has changed. All my worries have vanished.”

Participant in the PENSA Study

"It not only significantly improves cognition, but also reduces the risk of dementia" - TV3.

Dr. Rafael de la Torre, coordinator of the PENSA study and researcher at IMIM.